Wells Fargo’s Augmedix, Inc. Common Stock AUGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,000
| Closed | -$2.35K | – | 7306 |
|
|
2024
Q3 | $2.35K | Hold |
1,000
| – | – | ﹤0.01% | 6037 |
|
|
2024
Q2 | $880 | Sell |
1,000
-320
| -24% | -$660 | ﹤0.01% | 6101 |
|
|
2024
Q1 | $5.4K | Buy |
1,320
+50
| +4% | +$224 | ﹤0.01% | 5878 |
|
|
2023
Q4 | $7.43K | Buy |
1,270
+13
| +1% | +$68 | ﹤0.01% | 5898 |
|
|
2023
Q3 | $6.47K | Buy |
1,257
+49
| +4% | +$230 | ﹤0.01% | 5911 |
|
|
2023
Q2 | $5.81K | Buy |
1,208
+24
| +2% | +$83 | ﹤0.01% | 6050 |
|
|
2023
Q1 | $2.06K | Buy |
1,184
+3
| +0.3% | +$5 | ﹤0.01% | 6217 |
|
|
2022
Q4 | $1.84K | Buy |
1,181
+5
| +0.4% | +$6 | ﹤0.01% | 6028 |
|
|
2022
Q3 | $1K | Buy |
1,176
+51
| +5% | +$87 | ﹤0.01% | 6506 |
|
|
2022
Q2 | $2K | Buy |
1,125
+11
| +1% | +$25 | ﹤0.01% | 6400 |
|
|
2022
Q1 | $3K | Hold |
1,114
| – | – | ﹤0.01% | 6613 |
|
|
2021
Q4 | $3K | Buy |
+1,114
| New | +$4.04K | ﹤0.01% | 6834 |
|
Wells Fargo's AUGX Position: Q4 2024 in Review
Wells Fargo sold out of Augmedix, Inc. Common Stock (AUGX) in Q4 2024, closing a stake of 1,000 shares — an estimated $2.35K sold.
Wells Fargo first reported a position in AUGX in Q4 2021 and held it in 12 quarters. The position peaked at $7.43K in Q4 2023. 0 funds tracked by Wall St. Rank hold AUGX as of Q4 2024.
- Wells Fargo reported no remaining Augmedix, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Wells Fargo sold 1,000 Augmedix, Inc. Common Stock shares in Q4 2024, an estimated $2.35K.
- Wells Fargo first reported a position in Augmedix, Inc. Common Stock in Q4 2021 and held it in 12 quarters.
- Wells Fargo's Augmedix, Inc. Common Stock position peaked at $7.43K in Q4 2023.
- 0 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q4 2024.
Based on Wells Fargo's 13F filing for Q4 2024, filed 13 Feb 2025.